A person walks past the Pfizer Headquarters building in New York, December 7, 2020.
Carlo Allegri | Reuters
The trend of strong drug development and stock outperformance should continue for Pfizer, making it a smart bet for investors, according to BMO Capital Markets.
Ever since the U.K. government announced its so-called "mini-budget," markets in London have been gripped by turmoil. The chaos driven...
Demand for iron ore in China may have risen earlier this month, but the Swiss bank UBS says it's a...
The Federal Reserve's response to inflation is coming under intense scrutiny once more as investors grapple with a worsening economic...
Newly built houses in the Denham Court suburb of Sydney, Australia. Mortgage rates have fallen to below 2% in recent...
by Calculated Risk on 9/29/2022 09:02:00 PM Friday: o At 8:30 AM ET, Personal Income and Outlays, August 2022 and...
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!
